Good afternoon :)
Place Order
Add to Watchlist

Gennex Laboratories Ltd

GENNEX Share Price

13.112.42% (+0.31)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹291 cr, stock is ranked 2,214

Stock is 3.93x as volatile as Nifty

GENNEX Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹291 cr, stock is ranked 2,214

Stock is 3.93x as volatile as Nifty

GENNEX Performance & Key Metrics

GENNEX Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
17.681.65
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.696.410.79%

GENNEX Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

GENNEX Company Profile

Gennex Laboratories Limited is engaged in manufacturing of bulk drugs, intermediates and biotech products. Its product portfolio is spread over various product segments encompassing expectorants, muscle relaxants, analgesic and anti-fungal.

GENNEX Similar Stocks (Peers)

Compare with peers Compare with peers 

GENNEX Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
36.72
36.72
1Y Return
7.46%
7.46%
Buy Reco %
87.50
87.50
PE Ratio
22.80
22.80
1Y Return
0.08%
0.08%
Buy Reco %
73.33
73.33
PE Ratio
58.83
58.83
1Y Return
15.25%
15.25%
Buy Reco %
70.83
70.83
PE Ratio
18.89
18.89
1Y Return
1.76%
1.76%
Buy Reco %
55.17
55.17
PE Ratio
50.40
50.40
1Y Return
17.92%
17.92%
Buy Reco %
81.25
81.25
Compare with Peers

GENNEX Forecast

GENNEX Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

GENNEX

GENNEX

Income

Balance Sheet

Cash Flow

GENNEX Income Statement

GENNEX Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 21.22%, vs industry avg of 10.1%

Increasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.02% to 0.04%

Higher than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 53.85%, vs industry avg of 20.04%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue42.0344.6956.5856.6860.1762.5969.5691.62148.33148.34
Raw Materialssubtract24.4126.8836.3136.2035.1841.2348.1458.98121.19121.18
Power & Fuel Costsubtract1.972.262.853.303.013.174.394.67
Employee Costsubtract4.965.556.126.817.216.977.877.79
Selling & Administrative Expensessubtract3.133.014.233.343.443.434.423.29
Operating & Other expensessubtract2.923.882.272.724.651.03-3.91-5.05
Depreciation/Amortizationsubtract0.840.920.981.000.880.790.922.371.992.60
Interest & Other Itemssubtract0.710.730.790.750.740.881.353.083.612.99
Taxes & Other Itemssubtract0.400.620.800.691.021.171.453.325.425.10
EPS0.200.060.170.140.300.300.320.650.800.72
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00

GENNEX Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual report

PDF
 

GENNEX Stock Peers

GENNEX Past Performance & Peer Comparison

GENNEX Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Gennex Laboratories Ltd18.061.65
Sun Pharmaceutical Industries Ltd36.725.540.96%
Cipla Ltd22.803.841.07%
Torrent Pharmaceuticals Ltd58.8314.810.18%

GENNEX Stock Price Comparison

Compare GENNEX with any stock or ETF
Compare GENNEX with any stock or ETF
GENNEX
Loading...

GENNEX Holdings

GENNEX Shareholdings

GENNEX Promoter Holdings Trend

GENNEX Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

GENNEX Institutional Holdings Trend

GENNEX Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

GENNEX Shareholding Pattern

GENNEX Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding18.42%0.00%0.00%0.00%81.58%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

GENNEX Shareholding History

GENNEX Shareholding History

FebMarJunSepDec '24Mar0.00%0.00%0.00%0.00%0.00%0.00%

GENNEX Insider Trades & Bulk Stock Deals

GENNEX Insider Trades & Bulk Stock Deals

Loading...

smallcases containing GENNEX stock

smallcases containing GENNEX stock

Looks like this stock is not in any smallcase yet.

GENNEX Events

GENNEX Events

GENNEX Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

GENNEX has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

GENNEX Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

GENNEX has not given any dividends in last 5 years

GENNEX Dividends

GENNEX Dividends

Hmm, looks like data is unavailable here. Please come back after some time

GENNEX Stock News & Opinions

GENNEX Stock News & Opinions

Earnings
Gennex Laboratories consolidated net profit declines 48.44% in the March 2025 quarter

Net profit of Gennex Laboratories declined 48.44% to Rs 2.32 crore in the quarter ended March 2025 as against Rs 4.50 crore during the previous quarter ended March 2024. Sales rose 20.39% to Rs 40.33 crore in the quarter ended March 2025 as against Rs 33.50 crore during the previous quarter ended March 2024. For the full year,net profit rose 30.84% to Rs 16.12 crore in the year ended March 2025 as against Rs 12.32 crore during the previous year ended March 2024. Sales rose 59.04% to Rs 137.90 crore in the year ended March 2025 as against Rs 86.71 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales40.3333.50 20 137.9086.71 59 OPM %14.5118.72 -19.6925.30 - PBDT4.655.53 -16 23.5418.86 25 PBT4.105.30 -23 21.5516.49 31 NP2.324.50 -48 16.1212.32 31 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Gennex Laboratories to discuss results

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Gennex Laboratories consolidated net profit rises 79.15% in the December 2024 quarter

Net profit of Gennex Laboratories rose 79.15% to Rs 4.64 crore in the quarter ended December 2024 as against Rs 2.59 crore during the previous quarter ended December 2023. Sales rose 97.02% to Rs 37.71 crore in the quarter ended December 2024 as against Rs 19.14 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales37.7119.14 97 OPM %18.9625.08 - PBDT6.313.97 59 PBT5.823.52 65 NP4.642.59 79 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Gennex Laboratories to hold board meeting

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Earnings
Gennex Laboratories standalone net profit rises 56.39% in the September 2024 quarter

Net profit of Gennex Laboratories rose 56.39% to Rs 4.16 crore in the quarter ended September 2024 as against Rs 2.66 crore during the previous quarter ended September 2023. Sales rose 73.38% to Rs 24.69 crore in the quarter ended September 2024 as against Rs 14.24 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales24.6914.24 73 OPM %15.0327.88 - PBDT5.483.75 46 PBT5.013.55 41 NP4.162.66 56 Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Gennex Laboratories schedules board meeting

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Gennex Laboratories AGM scheduled

Gennex Laboratories announced that the 39th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

9 months agoCapital Market - Live
Corporate
Gennex Laboratories to hold board meeting

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 6 September 2024.Powered by Capital Market - Live

10 months agoCapital Market - Live
Earnings
Gennex Laboratories consolidated net profit rises 63.51% in the June 2024 quarter

Net profit of Gennex Laboratories rose 63.51% to Rs 4.66 crore in the quarter ended June 2024 as against Rs 2.85 crore during the previous quarter ended June 2023. Sales rose 71.74% to Rs 28.32 crore in the quarter ended June 2024 as against Rs 16.49 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales28.3216.49 72 OPM %23.6230.93 - PBDT5.964.37 36 PBT5.513.72 48 NP4.662.85 64 Powered by Capital Market - Live

10 months agoCapital Market - Live
Corporate
Gennex Laboratories to discuss results

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live

11 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Gennex Laboratories Ltd (GENNEX) today?

    The share price of GENNEX as on 9th July 2025 is ₹13.11. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Gennex Laboratories Ltd (GENNEX) share?

    The past returns of Gennex Laboratories Ltd (GENNEX) share are
    • Past 1 week: 0.81%
    • Past 1 month: -5.11%
    • Past 3 months: -1.84%
    • Past 6 months: -26.98%
    • Past 1 year: -13.28%
    • Past 3 years: 101.57%
    • Past 5 years: 181.32%

  3. What are the peers or stocks similar to Gennex Laboratories Ltd (GENNEX)?
  4. What is the market cap of Gennex Laboratories Ltd (GENNEX) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Gennex Laboratories Ltd (GENNEX) is ₹291.13 Cr as of 9th July 2025.

  5. What is the 52 week high and low of Gennex Laboratories Ltd (GENNEX) share?

    The 52-week high of Gennex Laboratories Ltd (GENNEX) is ₹29 and the 52-week low is ₹11.15.

  6. What is the PE and PB ratio of Gennex Laboratories Ltd (GENNEX) stock?

    The P/E (price-to-earnings) ratio of Gennex Laboratories Ltd (GENNEX) is 18.06. The P/B (price-to-book) ratio is 1.65.

  7. Which sector does Gennex Laboratories Ltd (GENNEX) belong to?

    Gennex Laboratories Ltd (GENNEX) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Gennex Laboratories Ltd (GENNEX) shares?

    You can directly buy Gennex Laboratories Ltd (GENNEX) shares on Tickertape. Simply sign up, connect your demat account and place your order.